Skip to main content

Table 7 Crosstabulation chemotherapy/tumor entity

From: Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years

  Tumor entity Total
ALT DLS MLS PLS LSM
Chemotherapy Yes Number of patients 0 5 6 6 0 17
% of chemotherapy 0,0% 29,4% 35,3% 35,3% 0,0% 100,0%
No Number of patients 56 16 32 6 1 111
% of chemotherapy 50,5% 14,4% 28,8% 5,4% 0,9% 100,0%
Total Number of patients 56 21 38 12 1 128
% of chemotherapy 43,8% 16,4% 29,7% 9,4% 0,8% 100,0%
  1. ALT Atypical lipomatous tumour, DLS Dedifferentiated liposarcoma, MLS Myxoid liposarcoma, PLS Pleomorphic liposarcoma, LSM Mixed-type liposarcoma